Bayer TA - Search Results

1

It all sticks together--the APP-related family of proteins and Alzheimer's disease.

Bayer TA, Cappai R, Masters CL, Beyreuther K, Multhaup G. Bayer TA, et al. Mol Psychiatry. 1999 Nov;4(6):524-8. doi: 10.1038/sj.mp.4000552. Mol Psychiatry. 1999. PMID: 10578233 Review.

2

Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer's disease.

Bayer TA, Paliga K, Weggen S, Wiestler OD, Beyreuther K, Multhaup G. Bayer TA, et al. Acta Neuropathol. 1997 Dec;94(6):519-24. doi: 10.1007/s004010050745. Acta Neuropathol. 1997. PMID: 9444352

3

Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.

Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K. Bayer TA, et al. Neurosci Lett. 1999 May 14;266(3):213-6. doi: 10.1016/s0304-3940(99)00311-0. Neurosci Lett. 1999. PMID: 10465711

4

Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.

Wirths O, Weickert S, Majtenyi K, Havas L, Kahle PJ, Okochi M, Haass C, Multhaup G, Beyreuther K, Bayer TA. Wirths O, et al. Among authors: bayer ta. Neuroreport. 2000 Nov 27;11(17):3737-41. doi: 10.1097/00001756-200011270-00029. Neuroreport. 2000. PMID: 11117482

5

Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport.

Bayer TA, Wirths O, Majtényi K, Hartmann T, Multhaup G, Beyreuther K, Czech C. Bayer TA, et al. Brain Pathol. 2001 Jan;11(1):1-11. doi: 10.1111/j.1750-3639.2001.tb00376.x. Brain Pathol. 2001. PMID: 11145195 Free PMC article. Review.

6

Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

Schäfer S, Wirths O, Multhaup G, Bayer TA. Schäfer S, et al. Among authors: bayer ta. J Neural Transm (Vienna). 2007 Mar;114(3):387-94. doi: 10.1007/s00702-006-0580-9. Epub 2006 Oct 31. J Neural Transm (Vienna). 2007. PMID: 17075721

7

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.

Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA. Wirths O, et al. Among authors: bayer ta. Acta Neuropathol. 2006 Apr;111(4):312-9. doi: 10.1007/s00401-006-0041-4. Epub 2006 Mar 7. Acta Neuropathol. 2006. PMID: 16520967

8

Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.

Schäfer S, Pajonk FG, Multhaup G, Bayer TA. Schäfer S, et al. Among authors: bayer ta. J Mol Med (Berl). 2007 Apr;85(4):405-13. doi: 10.1007/s00109-006-0140-7. Epub 2007 Jan 9. J Mol Med (Berl). 2007. PMID: 17211610

9

Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease.

Multhaup G, Scheuermann S, Schlicksupp A, Simons A, Strauss M, Kemmling A, Oehler C, Cappai R, Pipkorn R, Bayer TA. Multhaup G, et al. Among authors: bayer ta. Free Radic Biol Med. 2002 Jul 1;33(1):45-51. doi: 10.1016/s0891-5849(02)00806-7. Free Radic Biol Med. 2002. PMID: 12086681 Review.

10

Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain.

Lütjohann D, Brzezinka A, Barth E, Abramowski D, Staufenbiel M, von Bergmann K, Beyreuther K, Multhaup G, Bayer TA. Lütjohann D, et al. Among authors: bayer ta. J Lipid Res. 2002 Jul;43(7):1078-85. doi: 10.1194/jlr.m200071-jlr200. J Lipid Res. 2002. PMID: 12091492 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters